Status:
ACTIVE_NOT_RECRUITING
Cardiac Symptoms in Patients With Treated Graves' Disease
Lead Sponsor:
Ulla Feldt-Rasmussen
Conditions:
Graves Disease
Cardiac Arrhythmias
Eligibility:
All Genders
18-55 years
Brief Summary
Hyperthyroidism is a condition with increased production of thyroid hormone from the thyroid gland. Hyperthyroidism affects the heart's inotropy (contractile force) and chronotropy (rhythm). Therefore...
Detailed Description
Cardiac symptoms are common i patients with Graves' disease. These symptoms often disappear when hyperthyroidism is treated. However, a subgroup of patients with Graves' disease experiences persisting...
Eligibility Criteria
Inclusion
- Patient with Graves' disease
- Between the ages of 18 and 55 years
- Has been euthyroid for at least three months prior to inclusion
- Experiences cardiac symptoms
Exclusion
- Cardiovascular disease
- Deemed unsuitable by project staff (e.g. due to language problems)
- Pregnancy
- Alcohol abuse or other abuses
Key Trial Info
Start Date :
September 20 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 15 2025
Estimated Enrollment :
75 Patients enrolled
Trial Details
Trial ID
NCT06908369
Start Date
September 20 2021
End Date
October 15 2025
Last Update
April 3 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rigshospitalet
Copenhagen, Denmark